–
Galectin Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.2
FY22:
−38.4
FY23:
−38.1
FY24:
−42.4
FY25:
−20.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.1
FY22:
−38.3
FY23:
−37.8
FY24:
−42.1
FY25:
−19.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.5
FY22:
−38.8
FY23:
−41.1
FY24:
−47.0
FY25:
−30.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.5
FY22:
−38.8
FY23:
−41.1
FY24:
−47.0
FY25:
−30.8
All amounts in millions USD